Saxenda alternatives.
10 compounds compared to Saxenda, ranked by published evidence tier and regulatory status, not by what's marketed hardest.
Saxenda is a brand name for liraglutide. The alternatives below are compared to that molecule.
Liraglutide is approved and available, including as a generic injection, so alternatives searches here are mostly about the schedule and the generation gap. It is once-daily because its palmitic-acid acylation extends its action only that far, while the newer analogs in this class were engineered for once-weekly injection. People also look sideways after seeing weight-loss figures from later drugs. Two things are worth separating: Victoza is approved for type 2 diabetes and Saxenda for chronic weight management, so which alternative fits depends on which indication you are actually in. Cost is less often the driver here than it is for the newer molecules, since a generic exists.
Liraglutide is a long-acting, injectable glucagon-like peptide-1 (GLP-1) receptor agonist, an acylated analog of the human incretin hormone GLP-1.
- 01SemaglutideS tierFDA-approvedOzempic · Wegovy
Acts through the glp-1 receptor agonism pathway, like Liraglutide. FDA-approved.
- 02TirzepatideS tierFDA-approvedMounjaro · Zepbound
Acts through the glp-1 receptor agonism pathway, like Liraglutide. FDA-approved.
- 03SurvodutideB tierIn human trialsBI 456906
Acts through the glp-1 receptor agonism pathway, like Liraglutide. In human trials.
- 04MazdutideB tierIn human trialsIBI362 · LY3305677
Acts through the glp-1 receptor agonism pathway, like Liraglutide. In human trials.
- 05RetatrutideB tierIn human trialstriple agonist
Acts through the glp-1 receptor agonism pathway, like Liraglutide. In human trials.
- 06CagriSemaC tierIn human trialscagrilintide + semaglutide
Acts through the glp-1 receptor agonism pathway, like Liraglutide. In human trials.
- 07
- 08AOD-9604D tierResearch / preclinical
Same category: metabolic & glp-1. Research / preclinical.
- 09HGH Fragment 176-191F tierResearch / preclinicalhGH frag 176-191 · GH lipolytic fragment
Same category: metabolic & glp-1. Research / preclinical.
- 10
An “alternative” here means a compound that shares Liraglutide's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.